121.1102-Prediction of CVD events_Wilson, Cardiol Clin.pdf | 283.56Kb | February 22 2011 |
121a.1102-Association of CRP and CHD_CCGC, bmj.pdf | 144.78Kb | February 22 2011 |
130.1102-An epidemic of risk factors for CVD_Editorial, The Lancet.pdf | 85.95Kb | February 22 2011 |
134.1102-Lipid lowering therapy with statins for the Iary and IIary prevention of CVD_Lardizabal, Cardiol Clin.pdf | 857.04Kb | February 22 2011 |
139.1102-Women and Heart disease_Veronica Lee, Cardiol Clin.pdf | 173.71Kb | February 22 2011 |
140.1102-Intervention for CVD prevention_Gupta, Cardiol Clin.pdf | 692.35Kb | February 22 2011 |
214.1102-Carotid plaque morphology improves stroke risk prediction. New US score_Prati, CVD.pdf | 118.11Kb | February 22 2011 |
222.1102-Endovascular Stroke Treatment today_Grunwald, AJNR.pdf | 686.46Kb | February 22 2011 |
241.1102-Evaluation of Sx carotid plaques by tissue chraracterization using US and MRI_Yamada, CVD.pdf | 372.07Kb | February 22 2011 |
241.1102-Evolution of AthS carotid plaque morphology. Does ulcerated plaque heal. Serial MDCTA study_van Gils, CVD.pdf | 355.97Kb | February 22 2011 |
250.1103-Guideline on the management of patients with EC Carotid and Vertebral artery disease_ASA, ACCF, ._._, Circulation.pdf | 1.22Mb | February 22 2011 |
252.1102ep-The management of ASx CAS. Our assumptions when we are less radical_Makris, Angiology.pdf | 101.97Kb | February 22 2011 |
254.1102ep-1 Best Medical Therapy or Wishful thinking in carotid disease. Single-centre audit in Germany_Lutz, ejves.pdf | 391.93Kb | February 22 2011 |
322.1102-Assessment of balance in claudicants by computerized dynamic posturography_Mockford, Ann Vasc Surg.pdf | 333.95Kb | February 22 2011 |
325.1103-Exercise treadmill testing in patients with claudication, with and without diabetes_Mahé, Diabetic Med.pdf | 83.99Kb | February 22 2011 |
328ag.1102-PAD in octo and nonagerians. factors predicting survival_Koskela, Ann Vasc Surg.pdf | 412.80Kb | February 22 2011 |
331a.1102-1 Autologous BM-MC implantation reduces long-term major amputations in CLI patients_Idei, Circ CV Interv.pdf | 1.87Mb | February 22 2011 |
331a.1102-1 IA administration of BM-MC in CLI patients. PROVASA_Walter, Circ CV Interv.pdf | 1.21Mb | February 22 2011 |
331a.1102-2 Cell therapy for CLI. Moving forward one step at a time. Editorial,_Gupta, Circ CV Interv.pdf | 144.68Kb | February 22 2011 |
333.1102-1 Stent assisted BK PTA for limb salvage_Kawarada, J Endovasc Ther.pdf | 1.14Mb | February 22 2011 |
333.1102-2 BK angioplasty. To stent or Not to stent. Comment_Katsanos, J Endovasc Ther.pdf | 85.52Kb | February 22 2011 |
333.1102-Ambulatory PTA in patients with claudication_Maurel, Ann Vasc Surg.pdf | 198.58Kb | February 22 2011 |
351.1102-Assessment of RAS using both resting pressures and fractional flow reserve. DIAA vs DUS_Kadziela, Blood pressure.pdf | 150.61Kb | February 22 2011 |
352.1101ep-2010 Management of RAS_Colyer, Curr Tt Options in CV Med.pdf | 148.22Kb | February 22 2011 |
385.1102-Current management of true aneurysm of the dorsalis pedis artery_Bérard, Ann Vasc Surg.pdf | 820.57Kb | February 22 2011 |
600.1103-Update on VTE. RF, Mechanisms and Treatments_Machlus, ATVB.pdf | 250.71Kb | February 22 2011 |
631.1103-Leukocytes and the Natural history of DVT. Current concepts and Futuure directions_Saha, ATVB.pdf | 733.52Kb | February 22 2011 |
644.1102-Fondaparinux reduced a composite of VTE complications or death in LL-SVT_Ageno, ACP Journal Club.pdf | 238.58Kb | February 22 2011 |
672a.1103-The role of thrombolysis in the clinical management of DVT_Popuri, ATVB.pdf | 275.87Kb | February 22 2011 |
673.1102-Optimal duration of anticoagulation after VTE_Goldhaber, Circulation.pdf | 421.53Kb | February 22 2011 |